Information on the Target
Virbac is a prominent global player in the animal health sector, dedicated to the research, development, manufacturing, and distribution of veterinary products. With a commitment to animal welfare, the company has established a diverse portfolio that caters to both farm and companion animals. Their health solutions encompass a wide range of needs, including nutrition, dermatology, vaccines, and diagnostic products. Through innovation and extensive research and development efforts, Virbac strives to enhance animal health and ensure the well-being of animals across the globe.
Industry Overview in France
The animal health industry in France is robust and growing, driven by an increasing awareness of animal welfare and the rising demand for high-quality veterinary products. With a strong focus on innovation and sustainability, French companies have positioned themselves at the forefront of the market, catering to varied animal health needs. Major players, including Virbac, contribute significantly to advancements in veterinary medicines, vaccines, and diagnostics, which are vital not only for domestic agriculture but also for international markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
As global agricultural practices evolve to become more biosecure and efficient, France is leveraging its technological advancements in animal health to meet evolving consumer expectations. The pres
Similar Deals
Gannet BioChem → Laysan Bio
2026
Virbac
invested in
distributor in the Czech Republic and Slovakia
in 2023
in a Other deal